Genzyme

Genzyme focuses on six areas of medicine relating to lysosomal storage diseases, renal disease, orthopedics, transplant and immune diseases, oncology, genetics and diagnostics. The first orphan-drug for Genzyme that FDA approved was Ceredase, a drug for treating Gaucher disease.

Morgan Prestwich were retained by Genzyme to appoint a number of their medical vacancies in Europe and North America.